Suivant

Lecture automatique

GRACEcast-084_Lung-Cancer_ALK Inhibition: Science and Early Clinical Experience by Dr. Ben Solomon

6 Vues • 07/30/23
Partager
Intégrer
administrator
administrator
Les abonnés
0

http://cancergrace.org/

Dr. Ben Solomon of Peter MacCallum Cancer Centre in Melbourne Australia reviews ALK Inhibition from mechanism of action to activity and side effect profile of crizotinib, newly approved for patients with ALK-positive advanced non-small cell lung cancer.

Montre plus
0 commentaires sort Trier par
Commentaires de Facebook

Suivant

Lecture automatique